Biotage Achieves ISO 14001:2004 Certification
News Jun 14, 2016
Biotage is pleased to announce that they have achieved ISO 14001:2004 certification. This comes after years of dedicated work and close collaboration between employees, consultants and managerial staff.
In addition to establishing a series of quality standards regarding business practices and the environment, ISO 14001:2004 certification also comes with various other benefits to the titleholder, including: reduction of costs through efficient use of materials and management of legal compliance by prioritizing environmental risks.
“We at Biotage are incredibly honored to receive ISO 14001 certification of our environmental management systems that have been developed over the years. This certification is much more than just legal compliance; for us, it is a driver by which Biotage can effectively manage responsible business practices that seek to limit negative environmental impact through control of emissions and other potentially harmful actions” said Chris Williams, UK Managing Director, Biotage.
ISO 14001:2004 helps businesses like Biotage manage challenges, systems and risks concerning environmental performance. The certification serves as assurance to management, employees and external partners that the environmental impact of operations is being measured, monitored and continually improved.
Biotage’s official certification of its environmental management system was confirmed on 5th May 2016 by BSI, the reputable certification body that provides compliance, risk, and technical support.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria with antibiotics, researchers treated infected mice with molecules that block toxin formation in bacteria.READ MORE